Mednet Reports
PRIORITY PRESS - 23rd European Congress on Clinical Microbiology and Infectious Diseases
Strategies Evolve to Gain Control of Complicated Gram-Positive Infections
Berlin, Germany / April 27-30, 2013
Berlin - Due to evolving patterns of susceptibility, empiric and first-line therapies for challenging gram-positive infections must be adjusted, according to a series of reports at ECCMID. Alternatives to vancomycin, which is identified as...
PRIORITY PRESS - 23rd European Congress on Clinical Microbiology and Infectious Diseases
Recent Developments Promise New Guidelines for Management of C. difficile
Berlin, Germany / April 27-30, 2013
Berlin - Broad initiatives now underway are poised to stem the morbidity and mortality driven by a persistent rise in the incidence of Clostridium difficile infection (CDI). Due to progress in understanding risk factors and an expansion of...
PHYSICIAN PERSPECTIVE - Get with the PROTOCOL - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
St. Michael’s Hospital
April 2013
Reviewed and edited by: David H. Fitchett, MB, ChB, MD, FESC, FRCPCCardiologistSt. Michael’s HospitalToronto, Ontario IntroductionAntiplatelet therapy in the management of acute coronary syndromes (ACS) has recently been revised at...
PRIORITY PRESS - Annual General Meeting of the Canadian Society of Nephrology
New Insights in the Treatment of Atypical Hemolytic Uremic Syndrome
Montreal, Quebec / April 24-28, 2013
Montreal - Atypical hemolytic uremic syndrome (aHUS) is a rare condition caused by a genetic or acquired deficiency in the complement system. Its features include progressive and potentially fatal involvement of the kidneys and circulatory...
PRIORITY PRESS - Annual General Meeting of the Canadian Society of Nephrology
Exploring B-cell Targeted Therapy in the Management of Glomerulonephritis
Montreal, Québec / April 24-28, 2013
Montreal - Treatment of glomerulonephritis has long been dependent on the use of steroids plus cytotoxic or antiproliferative drugs. With the success of therapeutic monoclonal agents in other autoimmune diseases, their use in...
MEDICAL FRONTIERS - 48th Annual Meeting of the European Association for the Study of the Liver
New Protease Inhibitor Data Support Large Leap in Hepatitis C Virus Control
Amsterdam, The Netherlands / April 24-28, 2013
Amsterdam - In the rapidly evolving field of hepatitis C virus (HCV), protease inhibitors (PIs) are poised to provide additional incremental increases to sustained virologic remission (SVR) rates in difficult cases. Since their...
PRIORITY PRESS - Annual General Meeting of the Canadian Society of Nephrology
Type 2 Diabetes and Antihyperglycemics: A View from the Kidney
Montreal, Québec / April 24-28, 2013
Montreal - A new class of antihyperglycemic agents, the sodium-glucose co-transporter 2 inhibitors significantly reduce both blood pressure and weight beyond achieving glucose-lowering effects through an insulin-independent mechanism. As...
PHYSICIAN PERSPECTIVE - Get with the PROTOCOL - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
Centre de santé et de services sociaux de Chicoutimi
April 2013
Reviewed and edited by: Tomás Cieza, MDCardiologistCentre de santé et de services sociaux de ChicoutimiChicoutimi, QuebecPierre Bélisle, MDCardiologistCentre de santé et de services sociaux de...
PRIORITY PRESS - 8th Congress of the European Crohn’s and Colitis Organisation
The Potential of IV Iron Treatment in IBD Patients with Iron Deficiency Anemia
Vienna, Austria / February 14-16, 2013
Vienna - Anemia is the most common complication of inflammatory bowel disease (IBD), iron deficiency anemia (IDA) being the most prevalent cause. Correction of iron deficiency and IDA in IBD patients reduces the associated fatigue and...
PRIORITY PRESS - AMMI Canada - CACMID Annual Conference
New NACI Guidelines for Pneumococcal Disease Prevention in High-Risk Adults
Québec City, Quebec/ April 4-6, 2013
Québec City - Prevention of pneumococcal and other vaccine-preventable diseases is challenging in patients with immune deficiency. Vaccines are less immunogenic in this population. Many patients have not had recommended...
